US20180103645A1 - Methods for forming stabilized metal salt particles - Google Patents
Methods for forming stabilized metal salt particles Download PDFInfo
- Publication number
- US20180103645A1 US20180103645A1 US15/841,897 US201715841897A US2018103645A1 US 20180103645 A1 US20180103645 A1 US 20180103645A1 US 201715841897 A US201715841897 A US 201715841897A US 2018103645 A1 US2018103645 A1 US 2018103645A1
- Authority
- US
- United States
- Prior art keywords
- solution
- metal
- ppm
- particle size
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
- A01N59/16—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
- A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
- A61L12/088—Heavy metals
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
- C01G9/00—Compounds of zinc
- C01G9/006—Compounds containing, besides zinc, two ore more other elements, with the exception of oxygen or hydrogen
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B1/00—Optical elements characterised by the material of which they are made; Optical coatings for optical elements
- G02B1/04—Optical elements characterised by the material of which they are made; Optical coatings for optical elements made of organic materials, e.g. plastics
- G02B1/041—Lenses
- G02B1/043—Contact lenses
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2004/00—Particle morphology
- C01P2004/60—Particles characterised by their size
- C01P2004/64—Nanometer sized, i.e. from 1-100 nanometer
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2006/00—Physical properties of inorganic compounds
- C01P2006/80—Compositional purity
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2006/00—Physical properties of inorganic compounds
- C01P2006/80—Compositional purity
- C01P2006/82—Compositional purity water content
Definitions
- This invention relates to methods for forming stabilized metal salt particles.
- PVP polyvinyl pyrollidone
- the present invention relates to methods for forming stabilized metal salt particles. Specifically the present invention relates to a process comprising
- the stabilized metal salt particles may be added to a wide variety of polymers, either in the reactive mixture or in a compounding step.
- the metal salt particles are antimicrobial, and impart antimicrobial properties to the polymer to which they are added.
- antimicrobial means that the article exhibits one or more of the following properties, the inhibition of the adhesion of bacteria or other microbes to the article, the inhibition of the growth of bacteria or other microbes on article, and the killing of bacteria or other microbes on the surface of the article or in an area surrounding the article.
- adhesion of bacteria or other microbes to the article, the growth of bacteria or other microbes on lenses and the presence of bacterial or other microbes on the surface of article are collectively referred to as “microbial colonization.”
- the articles of the invention exhibit at least about 0.25 log reduction, in some embodiments at least about 0.5 log reduction, and in some embodiments at least about a 1.0 log reduction ( ⁇ 90% inhibition) of viable bacteria or other microbes.
- bacteria or other microbes include but are not limited to Pseudomonas aeruginosa, Acanthamoeba species, Staphyloccus. aureus, E. coli, Staphyloccus epidermidis , and Serratia marcesens.
- M may be any positively charged metal ion selected from, but not limited to, the following Al +3 , Cr +2 , Cr +3 , Cd +1 , Cd +2 , Co +2 , Co +3 , Ca +2 , Mg +2 , Ni +2 , Ti +2 , Ti +3 , Ti +4 , V +2 , V +3 , V +5 , Sr +2 , Fe +2 , Fe +3 , Au +2 , Au +3 , Au +1 , Ag +2 , Ag +1 , Pd +2 , Pd +4 , Pt +2 , Pt +4 , Cu +1 , Cu +2 , Mn +2 , Mn +3 , Mn +4 , Zn +2 , Se +4+2 and mixtures thereof.
- M may be selected from Al +3 , Co +2 , Co +3 , Ca +2 , Mg +2 , Ni +2 , Ti +2 , Ti +3 , Ti +4 , V +2 , V +3 , V +5 , Sr +2 , Fe +2 , Fe +3 , Au +2 , Au +3 , Au +1 , Ag +2 , Ag +1 , Pd +2 , Pd +4 , Pt +2 , Pt +4 , Cu +1 , Cu +2 , Mn +2 , Mn +3 , Mn +4 , Se +4 and Zn +2 and mixtures thereof.
- Examples of X include but are not limited to CO 3 ⁇ 2 , NO 3 ⁇ 1 , PO 4 ⁇ 3 , CI ⁇ 1 , I ⁇ 1 , Br ⁇ 1 , S ⁇ 2 , O ⁇ 2 , acetate, mixtures thereof and the like. Further X includes negatively charged ions containing CO 3 ⁇ 2 SO 4 ⁇ 2 , PO 4 ⁇ 3 , CI ⁇ 1 , I ⁇ 1 , Br ⁇ 1 , S ⁇ 2 , O ⁇ 2 , acetate and the like, such as C 1-5 alkylCO 2 ⁇ 1 .
- X may comprise CO 3 ⁇ 2 SO 4 ⁇ 2 , CI ⁇ 1 , I ⁇ 1 , Br ⁇ 1 , acetate and mixtures thereof.
- metal salts does not include zeolites, such as those disclosed in US-2003-0043341-A1. This patent application is hereby incorporated by reference in its entirety.
- the preferred a is 1, 2, or 3.
- the preferred b is 1, 2, or 3.
- the preferred metals ions are Mg +2 , Zn +2 , Cu +1 , Cu +2 , Au +2 , Au +3 , Au +1 , Pd +2 , Pd +4 , Pt +2 , Pt +4 , Ag +2 , and Ag +1 and mixtures thereof.
- the particularly preferred metal ion is Ag +1 .
- suitable metal salts include but are not limited to manganese sulfide, zinc oxide, zinc carbonate, calcium sulfate, selenium sulfide, copper iodide, copper sulfide, and copper phosphate.
- silver salts include but are not limited to silver carbonate, silver phosphate, silver sulfide, silver chloride, silver bromide, silver iodide, and silver oxide.
- the metal salt comprises at least one silver salt such as silver iodide, silver chloride, and silver bromide.
- the metal salt has a K sp of less than about 2 ⁇ 10 ⁇ 10 in pure water at 25° C. In one embodiment the metal salt has a solubility product constant of not more than about 2.0 ⁇ 10 ⁇ 17 moles/L.
- K sp Solubility-product constants
- the K sp is calculated as follows
- salt precursor refers to any compound or composition (including aqueous solutions) that contains a cation that may be substituted with metal ions. It is preferred that the salt precursor is soluble in selected solvent at about 1 ⁇ g/mL or greater.
- the term does not include zeolites as described US2003/0043341 entitled “Antimicrobial Contact Lenses and Methods of Use,” or activated silver as described in WO02/062402, entitled “Antimicrobial Contact Lenses Containing Activated Silver and Methods for Their Production”.
- salt precursors include but are not limited to inorganic molecules such as sodium chloride, sodium iodide, sodium bromide, lithium chloride, lithium sulfide, sodium sulfide, potassium sulfide, sodium tetrachloro argentate, mixtures thereof and the like.
- organic molecules include but are not limited to tetra-alkyl ammonium lactate, tetra-alkyl ammonium sulfate, tetra-alkyl phosphonium acetate, tetra-alkyl phosphonium sulfate, quaternary ammonium or phosphonium halides, such as tetra-alkyl ammonium chloride, tetra-alkyl phosphonium chloride, bromide or iodide, and the like.
- the precursor salt comprises sodium iodide.
- the salt precursor solution is formed by dissolving the salt precursor in at least one solvent.
- concentration of salt precursor in the salt precursor solution is desirably at least about at least about 1500 ppm up to the solubility limit for the salt precursor in the selected solvent, in some embodiments between about 5000 ppm and the solubility limit and in some embodiments between about 5000 ppm and about 50,000 ppm (5 wt %) and in other embodiments between about 5000 and about 20,000 ppm (2 wt %).
- metal agent refers to any composition (including aqueous solutions) containing metal ions.
- examples of such compositions include but are not limited to aqueous or organic solutions of silver nitrate, silver triflate, silver acetate, silver tetrafluoroborate, copper nitrate, copper sulfate, magnesium sulfate, zinc sulfate, mixtures thereof and the like.
- the metal agent solution is formed by dissolving the metal agent in at least one solvent.
- concentration of metal agent in the metal agent solution is desirably at least about at least about 1500 ppm up to the solubility limit for the metal agent in the selected solvent, in some embodiments between about 5000 ppm and the solubility limit, in some embodiments between about 5000 ppm and 50,000 ppm (5 wt %) and in other embodiments between about 5000 and about 20,000 ppm (2 wt %).
- Suitable solvents (a) dissolve the metal agent, salt precursor and dispersing agent, (b) do not reduce the metal agent to metal and (c) can be readily removed by known methods. Water, alcohols or mixtures thereof may be used.
- Suitable alcohols are capable of solubilizing the metal agent and salt precursor.
- alcohols such as t-amyl alcohol, tripropylene glycol monomethyl ether, and mixtures thereof and mixtures with water may be used. Water may also be used alone.
- At least one of the metal agent solution and the salt precursor solution further comprises at least one dispersing agent, and in one embodiment, the metal agent mixture further comprises at least one dispersing agent.
- Suitable dispersing agents include polymers which comprise functional groups with lone pair electrons. Examples of dispersing agents include hydroxyalkylmethylcellulose polymers, polyvinyl alcohol, polyvinyl pyrrolidone, polyethylene oxide, polysaccharides, such as starch, pectin, gelatin; polyacrylamide, including polydimethylacrylamide, polyacrylic acid, organoalkoxysilanes such as 3-aminopropyltriethoxysilane (APS), methyl-triethoxysilane (MTS), phenyl-trimethoxysilane (PTS), vinyl-triethoxysilane (VTS), and 3-glycidoxypropyltrimethoxysilane (GPS), polyethers, such as polyethylene glycol, polypropylene glycol, boric acid ester of
- the dispersing agent is selected from the group consisting of hydroxyalkylmethylcellulose polymers, polyvinyl alcohol, polyvinyl pyrrolidone, polyethylene oxide, glycerin, boric acid ester of glycerin (BAGE), gelatin and polyacrylic acid, and mixtures thereof.
- the dispersing agent is selected from the group consisting of hydroxypropylmethylcellulose, polyvinyl alcohol, polyvinyl pyrrolidone, polyethylene oxide, gelatin, glycerin and BAGE and mixtures thereof.
- the dispersing agent is selected from the group consisting of polyvinyl alcohol, polyvinyl pyrrolidone, and polyethylene oxide, and mixtures thereof.
- the dispersing agent is a polymer
- it can have a range of molecular weights. Molecular weights from about 1000 up to several million may be used. The upper molecular weight limit is bounded only by the solubility of the dispersing agent in the metal salt mixture, the salt precursor mixture and the reactive mixture.
- glycoside polymers such as gelatin and methyl cellulose the molecular weight may be above a million.
- non-glycoside polymers like polyvinyl alcohol, polyvinyl pyrrolidone and poly acrylic acid
- the molecular weight may range from about 2,500 to about 2,000,000, in some embodiments from about 10,000 to about 1,800,000 Daltons, and in other embodiments from about 20,000 to about 1,500,000 Daltons. In some embodiments molecular weights of greater than about 50,000 Daltons may be used, as dispersing agents in this range provide better stabilization in some polymer systems.
- the molecular weight of the dispersion-stabilizing polymers can be also expressed by the K-value, based on kinematic viscosity measurements, as described in Encyclopedia of Polymer Science and
- non-glycoside dispersing agent polymers may have K-values from about 5 to about 150, in some embodiments from about 5 to about 100, from about 5 to about 70 and in other embodiments from about 5 to about 50.
- Stabilized metal salt nanoparticles may be formed by forming a salt precursor solution comprising at least one salt precursor;
- a metal agent solution comprising a complex formed from at least one dispersing agent having a weight average molecular weight of at least about 1000 and at least one metal agent;
- the dispersing agent is included in either or both the metal agent and salt precursor solutions, or can be included in a third solution, into which the metal agent and salt precursor solutions are added.
- the dispersing agents may be the same or different.
- the dispersing agent is included in an amount sufficient to provide a particle size of less than about 500 nm (“particle size stabilizing effective amount”). In embodiments where the clarity of the final article is important, the particle size is less than about 200 nm, in some embodiments less than about 100 nm, and in others still, less than about 50 nm. In one embodiment, at least about 20 weight % dispersing agent, is used in at least one solution to insure that the desired particle size is achieved. In another embodiment, between about 20 and about 50 weight % dispersing agent is used. In some embodiments the molar ratio of dispersing agent unit to metal agent is at least about 1.5, at least about 2, and in some embodiments at least about 4. As used herein, dispersing agent unit is a repeating unit within the dispersing agent. In one embodiment the metal agent solution comprises dispersing agent. In some embodiments it will be convenient to have the same concentration of dispersing agent in both solutions.
- the upper concentration limit for dispersing agent in the solutions may be determined by solubility of the dispersing agent in the selected solvent, and ease of handling of the solutions.
- each solution has a viscosity of less than about 50 cps.
- the product solution may have up to about 50 weight % dispersing agent.
- the metal agent and salt precursor solutions may have the same or different concentrations of dispersing agent. All weight % are based upon the total weight of all components in the solution.
- the mixing of the solutions may be conducted at room temperature, and may beneficially include stirring. Stirring speeds at or above which a vortex is created may be used. The selected stirring speed should not cause frothing, foaming or loss of solution from the mixing container. Stirring is continued throughout addition.
- Mixing may be conducted at ambient pressure, or decreased pressure. In some embodiments, mixing may cause the solution to froth or foam. Foaming or frothing is undesirable as it may cause pockets of higher concentration of the metal salt to form, which results in larger than desired particle size. In these cases decreased pressure may be used.
- the pressure can be any pressure between ambient and the vapor pressure for the selected solvent. In one embodiment, where water is the solvent, the pressures may be between ambient and about 40 mbar.
- the rate of addition of the salt precursor and metal agent solutions is selected to maintain a clear solution throughout mixing. Slight localized haze may be acceptable so long as the solution clears with stirring. Clarity of the solution may be observed visually or monitored using UV-VIS spectroscopy. Suitable addition rates may be determined by preparing a series of solutions having the desired concentration, and monitoring the clarity of the solution at different addition rates. This procedure is exemplified in Examples 2-7. Including dispersing agent in the salt precursor solution may also allow for faster rates of addition.
- the metal agent and dispersing agent are allowed to mix under complex-forming conditions, including a complex-forming time before mixing with the salt precursor solution. It is believed that the dispersing agent in the metal agent solution forms a complex with the metal agent. In this embodiment, it is desirable to allow the metal agent to fully complex with the dispersing agent prior to combining the metal agent solution and the salt precursor solution.
- “Fully complexed” means that substantially all the metal ions have complexed with at least one dispersing agent. “Substantially all” means at least about 90%, and in some embodiments at least about 95% of said metal ions have complexed with at least one dispersing agent.
- the complex-forming time may be monitored in solution via spectroscopy, such as via UV-VIS or FTIR.
- the spectra of the metal agent solution without the dispersing agent is measured.
- the spectra of the metal agent solution is monitored after addition of the dispersing agent, and the change in spectra is monitored.
- the complex-forming time is the time at which the spectral change plateaus.
- complexation time may be measured empirically by forming a series of metal agent-dispersing agent solutions having the same concentration, allowing each solution to mix for a different time (for example 1, 3, 6, 12, 24, 72 hours and 1 week), and mixing each metal agent-dispersing agent solution batch-wise with the salt precursor solution.
- the metal agent-dispersing agent solutions which are mixed for complex-forming times will form clear solutions when the metal agent and salt precursor solutions are poured together directly without controlling the rate of addition. For example, 20 ml of metal agent solution may be added to 20 ml of salt precursor solution in 1 second or less.
- Complexation conditions include complexation time (discussed above), temperature, ratio of the dispersing agent to the metal agent and stirring rates. Increasing the temperature, molar ratio of dispersing agent to metal agent and stirring rate, will decrease complexation time. Those of skill in the art will, with reference to the teachings herein, can vary the conditions to achieve the disclosed complexation levels.
- the mixing conditions may be selected to bias reactions in the mixture to forming the dispersing agent-metal agent complex over the formation of uncomplexed metal salt.
- This biasing may be achieved by controlling the (a) concentration of dispersing agent in the salt precursor, or the solution into which the salt precursor and metal agent solutions are added and (b) rate of mixing of the metal agent and salt precursor solutions.
- the nanoparticle-containing product solution may be dried. Any conventional drying equipment may be used such as freeze dryers, spray dryers and the like. Drying equipment and processes are well known in the art.
- An example of a suitable spray dryer is a cyclone spray dryer, such as those available from GEA Niro, Inc. For spray drying the temperature of the spray inlet is above the flash point for the selected solvent.
- Freeze dryers are available from numerous manufacturers, including GEA Niro, Inc. Freeze drying temperatures and pressures are selected to sublimate the solvent as is well known by those of skill in the art. Any temperature within conventional ranges for the method selected may be used.
- the product solution is dried until the resulting powder has a solvent content of less than about 10 weight %, in some embodiments less than about 5 weight % and in some embodiments less than about 2 weight %. Higher solvent concentrations may be appropriate where the solvent used to form the stabilized metal salt is compatible with the reaction mixture used to form the polymeric article.
- the powder is a stabilized metal salt nanoparticle having a particle size of up to about 100 nm, up to about 50 nm, and in some embodiments up to about 15 nm as measured by as measured by transmission electron microscopy or dynamic light scattering by dispersing in water.
- the stabilized metal salt powder may be added directly to polymeric reaction mixtures, or compounded with thermoplastic polymers, which can then be used to form polymeric coatings.
- the stabilized metal salt powder may also be added to a wide variety of coating formulations.
- the amount of stabilized metal salt powder to be added may be readily calculated to provide the desired level of functionality. For example, where the metal salt is antimicrobial, the amount of metal salt powder added to the bulk polymer or coating formulation may be readily calculated to provide the desired level of antimicrobial metal ion.
- Particle size was measured using laser light scattering or dynamic light scattering. For samples with a particle size range greater than about 500nm a Horiba-LA930 laser diffraction particle size analyzer was used. The instrument check was performed from the blank % T values. One mL of the sample solution was introduced into the circulation bath which contained 150 mL of water as medium. A relative refractive index of 1.7-0.1 i and a circulation speed of 5 was used. The samples were ultrasonicated for two minutes prior to measurement using ultrasonication in the instrument. Triton° X-100 (commercially available from Union Carbide) (0.1%) was used as a surfactant in the analysis. Triplicate analysis was performed and the traces were compared to make sure that they coincided with each other. The instrument provided a report containing a graph of the particle size distribution along with values for the mean particle size.
- a Malvern 4700 dynamic light scattering apparatus was used for samples with a particle size range less than about 500 nm. The instrument check was performed prior to analysis of the samples using NIST traceable standard size polystyrene particles. One ml of the sample was diluted to 20 ml with water and the samples were sonicated for one minute using Branson Ultrasonic probe and both relative refractive index and viscosity values were entered in the software. The instrument provides a report containing a graph of the particle size distribution along with values for the mean particle size.
- Metal agent and salt precursor solutions were formed as follows: 10,000 ppm AgNO 3 was dissolved with stirring in 200 gm of a 50 w/w% solution of PVP K12 in Dl water. Nal (10,000 ppm) was dissolved with stirring in 200 gm of a 50 w/w% solution of PVP K12 in Dl water. The metal salt solution containing AgNO 3 was added to the salt precursor solution at a rate of 200 gm/hour with stirring at 2013 rpm. The metal salt solution was spray dried in air. The inlet temperature was 185° C., the outlet temperature was 90° C. and the feed rate was 2.7 kg/hr. The stabilized Agl nanoparticles had a water content of less than 5 weight %.
- a 100,000 ppm solution of PVP K12 was made in Dl water. This solution (solution A) provided the base for making Nal and AgNO 3 solutions. Solutions of approximately 1500 ppm, 5000 ppm and 10000 ppm of each of Nal and AgNO 3 were made. Each solution was stirred until no visible particles were observed. A 20 mL portion of Nal solution was placed in a clean jar and magnetic stirrer was placed inside. The stirrer was set at 300 rpm and 20 ml. of AgNO 3 was added to the Nal solution at the rate shown in Table 1, below. All mixing was conducted at ambient temperature. The haze of the solution was subjectively assessed at the end of the listed addition time and results are reported in Table 1, below. The Example was repeated for each concentration and addition rate shown in Table 1.
- Example 7 was repeated, except that the metal agent and salt precursor solutions were mixed for about ⁇ 5 days, and then batch-wise mixed (poured together in about 1 second). The result was a clear silver iodide solution.
- Example 10 was repeated, except the dispersing agents listed in Table 4 were used instead of PVP, and at the concentrations listed in Table 4. Particle size measurements were carried out on the resulting Agl dispersions using laser light scattering (16, 17 and 19) and photon correlation spectrophotometry (18, 20). Data is reported as z-average of the particle size distribution.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Optics & Photonics (AREA)
- General Physics & Mathematics (AREA)
- Wood Science & Technology (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- Agronomy & Crop Science (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention relates to a process for forming stabilized metal salt particles.
Description
- This invention relates to methods for forming stabilized metal salt particles.
- Processes for forming colloidal solutions and powders of silver (0) stabilized by polyvinyl pyrollidone (PVP) have been disclosed. In the first step of these processes PVP has been mixed with silver nitrate to form a PVP-silver ion complex. The silver ion is then reduced with agents such as hydrazine hydrate or glucose and sodium hydroxide. A process which uses the PVP-silver ion complex to for stabilized metal salt particles is not disclosed.
- The present invention relates to methods for forming stabilized metal salt particles. Specifically the present invention relates to a process comprising
-
- a. forming a first solution comprising at least one salt precursor;
- b. forming a second solution comprising a complex formed from at least one metal agent and at least one dispersing agent in a particle size stabilizing effective amount;
- c. adding said second solution to said first solution to form a clear product solution comprising stabilized metal salt particles having an average particle size of less than about 200 nm;
- d. drying said product solution to form an antimicrobial metal salt powder comprising 0.01 to about 10 weight % metal in the antimicrobial metal salt powder.
- The stabilized metal salt particles may be added to a wide variety of polymers, either in the reactive mixture or in a compounding step. In one embodiment the metal salt particles are antimicrobial, and impart antimicrobial properties to the polymer to which they are added.
- As used herein, the term, “antimicrobial” means that the article exhibits one or more of the following properties, the inhibition of the adhesion of bacteria or other microbes to the article, the inhibition of the growth of bacteria or other microbes on article, and the killing of bacteria or other microbes on the surface of the article or in an area surrounding the article. For purposes of this invention, adhesion of bacteria or other microbes to the article, the growth of bacteria or other microbes on lenses and the presence of bacterial or other microbes on the surface of article are collectively referred to as “microbial colonization.” Preferably, the articles of the invention exhibit at least about 0.25 log reduction, in some embodiments at least about 0.5 log reduction, and in some embodiments at least about a 1.0 log reduction (≥90% inhibition) of viable bacteria or other microbes. Such bacteria or other microbes include but are not limited to Pseudomonas aeruginosa, Acanthamoeba species, Staphyloccus. aureus, E. coli, Staphyloccus epidermidis, and Serratia marcesens.
- As use herein, the term “metal salt” means any molecule having the general formula [Mq+]z[Xz−]b wherein X contains any negatively charged ion, a, b, q and z are independently integers ≥1, q(a)=z(b). M may be any positively charged metal ion selected from, but not limited to, the following Al+3, Cr+2, Cr+3, Cd+1, Cd+2, Co+2, Co+3, Ca+2, Mg+2, Ni+2, Ti+2, Ti+3, Ti+4, V+2, V+3, V+5, Sr+2, Fe+2, Fe+3, Au+2, Au+3, Au+1, Ag+2, Ag+1, Pd+2, Pd+4, Pt+2, Pt+4, Cu+1, Cu+2, Mn+2, Mn+3, Mn+4, Zn+2, Se+4+2 and mixtures thereof. In another embodiment, M may be selected from Al+3, Co+2, Co+3, Ca+2, Mg+2, Ni+2, Ti+2, Ti+3, Ti+4, V+2, V+3, V+5, Sr+2, Fe+2, Fe+3, Au+2, Au+3, Au+1, Ag+2, Ag+1, Pd+2, Pd+4, Pt+2, Pt+4, Cu+1, Cu+2, Mn+2, Mn+3, Mn+4, Se+4 and Zn+2 and mixtures thereof. Examples of X include but are not limited to CO3 −2, NO3 −1, PO4 −3, CI−1, I−1, Br−1, S−2, O−2, acetate, mixtures thereof and the like. Further X includes negatively charged ions containing CO3 −2 SO4 −2, PO4 −3, CI−1, I−1, Br−1, S−2, O−2, acetate and the like, such as C1-5alkylCO2 −1. In another embodiment, X may comprise CO3 −2SO4 −2, CI−1, I−1, Br−1, acetate and mixtures thereof. As used herein the term metal salts does not include zeolites, such as those disclosed in US-2003-0043341-A1. This patent application is hereby incorporated by reference in its entirety. The preferred a is 1, 2, or 3. The preferred b is 1, 2, or 3. The preferred metals ions are Mg+2, Zn+2, Cu+1, Cu+2, Au+2, Au+3, Au+1, Pd+2, Pd+4, Pt+2, Pt+4, Ag+2, and Ag+1 and mixtures thereof. The particularly preferred metal ion is Ag+1. Examples of suitable metal salts include but are not limited to manganese sulfide, zinc oxide, zinc carbonate, calcium sulfate, selenium sulfide, copper iodide, copper sulfide, and copper phosphate. Examples of silver salts include but are not limited to silver carbonate, silver phosphate, silver sulfide, silver chloride, silver bromide, silver iodide, and silver oxide. In one embodiment the metal salt comprises at least one silver salt such as silver iodide, silver chloride, and silver bromide.
- For embodiments where the stabilized metal salt is to be incorporated into an article in contact with water miscible solutions, including water miscible bodily fluids like blood, urine, tears or saliva, and antimicrobial efficacy of greater than about 12 hours is desired, the metal salt has a Ksp of less than about 2×10−10 in pure water at 25° C. In one embodiment the metal salt has a solubility product constant of not more than about 2.0×10−17 moles/L.
- As used herein, the term “pure” refers to the quality of the water used as defined in the CRC Handbook of Chemistry and Physics, 78th Edition, CRC Press, Boca Raton Florida, 1993. Solubility-product constants (Ksp) measured in pure water at 25° C. for various salts are published in CRC Handbook of Chemistry and Physics, 78th Edition, CRC Press, Boca Raton Fla., 1993) For example, if the metal salt is silver carbonate (Ag2CO3), the Ksp is expressed by the following equation
-
Ag2CO3(s)→2Ag+(aq)+CO3 2−(aq) - The Ksp is calculated as follows
-
Ksp=[Ag+]2[CO3 2] - As silver carbonate dissolves, there is one carbonate anion in solution for every two silver cations, [CO3 2−]=½[Ag+], and the solubility-product constant equation can be rearranged to solve for the dissolved silver concentration as follows
-
Ksp=[Ag+]2(½[Ag+])=½[Ag+]3 -
[Ag+]=(2Ksp)1/3 - The term “salt precursor” refers to any compound or composition (including aqueous solutions) that contains a cation that may be substituted with metal ions. It is preferred that the salt precursor is soluble in selected solvent at about 1 μg/mL or greater. The term does not include zeolites as described US2003/0043341 entitled “Antimicrobial Contact Lenses and Methods of Use,” or activated silver as described in WO02/062402, entitled “Antimicrobial Contact Lenses Containing Activated Silver and Methods for Their Production”. Examples of salt precursors include but are not limited to inorganic molecules such as sodium chloride, sodium iodide, sodium bromide, lithium chloride, lithium sulfide, sodium sulfide, potassium sulfide, sodium tetrachloro argentate, mixtures thereof and the like. Examples of organic molecules include but are not limited to tetra-alkyl ammonium lactate, tetra-alkyl ammonium sulfate, tetra-alkyl phosphonium acetate, tetra-alkyl phosphonium sulfate, quaternary ammonium or phosphonium halides, such as tetra-alkyl ammonium chloride, tetra-alkyl phosphonium chloride, bromide or iodide, and the like. In one embodiment the precursor salt comprises sodium iodide.
- The salt precursor solution is formed by dissolving the salt precursor in at least one solvent. The concentration of salt precursor in the salt precursor solution is desirably at least about at least about 1500 ppm up to the solubility limit for the salt precursor in the selected solvent, in some embodiments between about 5000 ppm and the solubility limit and in some embodiments between about 5000 ppm and about 50,000 ppm (5 wt %) and in other embodiments between about 5000 and about 20,000 ppm (2 wt %).
- The term “metal agent” refers to any composition (including aqueous solutions) containing metal ions. Examples of such compositions include but are not limited to aqueous or organic solutions of silver nitrate, silver triflate, silver acetate, silver tetrafluoroborate, copper nitrate, copper sulfate, magnesium sulfate, zinc sulfate, mixtures thereof and the like.
- The metal agent solution is formed by dissolving the metal agent in at least one solvent. The concentration of metal agent in the metal agent solution is desirably at least about at least about 1500 ppm up to the solubility limit for the metal agent in the selected solvent, in some embodiments between about 5000 ppm and the solubility limit, in some embodiments between about 5000 ppm and 50,000 ppm (5 wt %) and in other embodiments between about 5000 and about 20,000 ppm (2 wt %). Suitable solvents (a) dissolve the metal agent, salt precursor and dispersing agent, (b) do not reduce the metal agent to metal and (c) can be readily removed by known methods. Water, alcohols or mixtures thereof may be used. Suitable alcohols are capable of solubilizing the metal agent and salt precursor. When silver nitrate and sodium iodide are used as the metal agent and salt precursor, alcohols such as t-amyl alcohol, tripropylene glycol monomethyl ether, and mixtures thereof and mixtures with water may be used. Water may also be used alone.
- At least one of the metal agent solution and the salt precursor solution further comprises at least one dispersing agent, and in one embodiment, the metal agent mixture further comprises at least one dispersing agent. Suitable dispersing agents include polymers which comprise functional groups with lone pair electrons. Examples of dispersing agents include hydroxyalkylmethylcellulose polymers, polyvinyl alcohol, polyvinyl pyrrolidone, polyethylene oxide, polysaccharides, such as starch, pectin, gelatin; polyacrylamide, including polydimethylacrylamide, polyacrylic acid, organoalkoxysilanes such as 3-aminopropyltriethoxysilane (APS), methyl-triethoxysilane (MTS), phenyl-trimethoxysilane (PTS), vinyl-triethoxysilane (VTS), and 3-glycidoxypropyltrimethoxysilane (GPS), polyethers, such as polyethylene glycol, polypropylene glycol, boric acid ester of glycerin (BAGE), silicone macromers having molecular weights greater than about 10,000 and comprising groups which increase viscosity, such as hydrogen bonding groups, such as but not limited to hydroxyl groups and urethane groups and mixtures thereof.
- In one embodiment the dispersing agent is selected from the group consisting of hydroxyalkylmethylcellulose polymers, polyvinyl alcohol, polyvinyl pyrrolidone, polyethylene oxide, glycerin, boric acid ester of glycerin (BAGE), gelatin and polyacrylic acid, and mixtures thereof. In another embodiment the dispersing agent is selected from the group consisting of hydroxypropylmethylcellulose, polyvinyl alcohol, polyvinyl pyrrolidone, polyethylene oxide, gelatin, glycerin and BAGE and mixtures thereof. In yet another embodiment the dispersing agent is selected from the group consisting of polyvinyl alcohol, polyvinyl pyrrolidone, and polyethylene oxide, and mixtures thereof.
- Where the dispersing agent is a polymer, it can have a range of molecular weights. Molecular weights from about 1000 up to several million may be used. The upper molecular weight limit is bounded only by the solubility of the dispersing agent in the metal salt mixture, the salt precursor mixture and the reactive mixture. For glycoside polymers such as gelatin and methyl cellulose the molecular weight may be above a million. For non-glycoside polymers like polyvinyl alcohol, polyvinyl pyrrolidone and poly acrylic acid, the molecular weight may range from about 2,500 to about 2,000,000, in some embodiments from about 10,000 to about 1,800,000 Daltons, and in other embodiments from about 20,000 to about 1,500,000 Daltons. In some embodiments molecular weights of greater than about 50,000 Daltons may be used, as dispersing agents in this range provide better stabilization in some polymer systems.
- Alternatively, the molecular weight of the dispersion-stabilizing polymers can be also expressed by the K-value, based on kinematic viscosity measurements, as described in Encyclopedia of Polymer Science and
- Engineering, N-Vinyl Amide Polymers, Second edition, Vol 17, pgs. 198-257, John Wiley & Sons Inc. When expressed in this manner, non-glycoside dispersing agent polymers may have K-values from about 5 to about 150, in some embodiments from about 5 to about 100, from about 5 to about 70 and in other embodiments from about 5 to about 50.
- Stabilized metal salt nanoparticles may be formed by forming a salt precursor solution comprising at least one salt precursor;
- forming a metal agent solution comprising a complex formed from at least one dispersing agent having a weight average molecular weight of at least about 1000 and at least one metal agent;
-
- adding one solution to the other at a rate sufficient to maintain a clear solution throughout addition and to form a product solution comprising stabilized metal salt nanoparticles having a mean particle size of less than about 50 nm; and drying said stabilized salt nanoparticles.
- Any of the dispersing agents described above may be used. The dispersing agent is included in either or both the metal agent and salt precursor solutions, or can be included in a third solution, into which the metal agent and salt precursor solutions are added. In embodiments where both the salt precursor solution and metal agent solutions comprise at least one dispersing agent, the dispersing agents may be the same or different.
- The dispersing agent is included in an amount sufficient to provide a particle size of less than about 500 nm (“particle size stabilizing effective amount”). In embodiments where the clarity of the final article is important, the particle size is less than about 200 nm, in some embodiments less than about 100 nm, and in others still, less than about 50 nm. In one embodiment, at least about 20 weight % dispersing agent, is used in at least one solution to insure that the desired particle size is achieved. In another embodiment, between about 20 and about 50 weight % dispersing agent is used. In some embodiments the molar ratio of dispersing agent unit to metal agent is at least about 1.5, at least about 2, and in some embodiments at least about 4. As used herein, dispersing agent unit is a repeating unit within the dispersing agent. In one embodiment the metal agent solution comprises dispersing agent. In some embodiments it will be convenient to have the same concentration of dispersing agent in both solutions.
- The upper concentration limit for dispersing agent in the solutions may be determined by solubility of the dispersing agent in the selected solvent, and ease of handling of the solutions. In one embodiment, each solution has a viscosity of less than about 50 cps. In one embodiment the product solution may have up to about 50 weight % dispersing agent. As described above, the metal agent and salt precursor solutions may have the same or different concentrations of dispersing agent. All weight % are based upon the total weight of all components in the solution.
- The mixing of the solutions may be conducted at room temperature, and may beneficially include stirring. Stirring speeds at or above which a vortex is created may be used. The selected stirring speed should not cause frothing, foaming or loss of solution from the mixing container. Stirring is continued throughout addition.
- Mixing may be conducted at ambient pressure, or decreased pressure. In some embodiments, mixing may cause the solution to froth or foam. Foaming or frothing is undesirable as it may cause pockets of higher concentration of the metal salt to form, which results in larger than desired particle size. In these cases decreased pressure may be used. The pressure can be any pressure between ambient and the vapor pressure for the selected solvent. In one embodiment, where water is the solvent, the pressures may be between ambient and about 40 mbar.
- The rate of addition of the salt precursor and metal agent solutions is selected to maintain a clear solution throughout mixing. Slight localized haze may be acceptable so long as the solution clears with stirring. Clarity of the solution may be observed visually or monitored using UV-VIS spectroscopy. Suitable addition rates may be determined by preparing a series of solutions having the desired concentration, and monitoring the clarity of the solution at different addition rates. This procedure is exemplified in Examples 2-7. Including dispersing agent in the salt precursor solution may also allow for faster rates of addition.
- In another embodiment, where faster addition rates are desired, the metal agent and dispersing agent are allowed to mix under complex-forming conditions, including a complex-forming time before mixing with the salt precursor solution. It is believed that the dispersing agent in the metal agent solution forms a complex with the metal agent. In this embodiment, it is desirable to allow the metal agent to fully complex with the dispersing agent prior to combining the metal agent solution and the salt precursor solution. “Fully complexed” means that substantially all the metal ions have complexed with at least one dispersing agent. “Substantially all” means at least about 90%, and in some embodiments at least about 95% of said metal ions have complexed with at least one dispersing agent.
- The complex-forming time may be monitored in solution via spectroscopy, such as via UV-VIS or FTIR. The spectra of the metal agent solution without the dispersing agent is measured. The spectra of the metal agent solution is monitored after addition of the dispersing agent, and the change in spectra is monitored. The complex-forming time is the time at which the spectral change plateaus.
- Alternatively, complexation time may be measured empirically by forming a series of metal agent-dispersing agent solutions having the same concentration, allowing each solution to mix for a different time (for example 1, 3, 6, 12, 24, 72 hours and 1 week), and mixing each metal agent-dispersing agent solution batch-wise with the salt precursor solution. The metal agent-dispersing agent solutions which are mixed for complex-forming times will form clear solutions when the metal agent and salt precursor solutions are poured together directly without controlling the rate of addition. For example, 20 ml of metal agent solution may be added to 20 ml of salt precursor solution in 1 second or less.
- Complexation conditions include complexation time (discussed above), temperature, ratio of the dispersing agent to the metal agent and stirring rates. Increasing the temperature, molar ratio of dispersing agent to metal agent and stirring rate, will decrease complexation time. Those of skill in the art will, with reference to the teachings herein, can vary the conditions to achieve the disclosed complexation levels.
- If the metal agent and dispersing agent are not fully complexed, the mixing conditions may be selected to bias reactions in the mixture to forming the dispersing agent-metal agent complex over the formation of uncomplexed metal salt. This biasing may be achieved by controlling the (a) concentration of dispersing agent in the salt precursor, or the solution into which the salt precursor and metal agent solutions are added and (b) rate of mixing of the metal agent and salt precursor solutions.
- Once the metal agent and salt precursor solutions have been mixed, the nanoparticle-containing product solution may be dried. Any conventional drying equipment may be used such as freeze dryers, spray dryers and the like. Drying equipment and processes are well known in the art. An example of a suitable spray dryer is a cyclone spray dryer, such as those available from GEA Niro, Inc. For spray drying the temperature of the spray inlet is above the flash point for the selected solvent.
- Freeze dryers are available from numerous manufacturers, including GEA Niro, Inc. Freeze drying temperatures and pressures are selected to sublimate the solvent as is well known by those of skill in the art. Any temperature within conventional ranges for the method selected may be used.
- The product solution is dried until the resulting powder has a solvent content of less than about 10 weight %, in some embodiments less than about 5 weight % and in some embodiments less than about 2 weight %. Higher solvent concentrations may be appropriate where the solvent used to form the stabilized metal salt is compatible with the reaction mixture used to form the polymeric article. The powder is a stabilized metal salt nanoparticle having a particle size of up to about 100 nm, up to about 50 nm, and in some embodiments up to about 15 nm as measured by as measured by transmission electron microscopy or dynamic light scattering by dispersing in water.
- The stabilized metal salt powder may be added directly to polymeric reaction mixtures, or compounded with thermoplastic polymers, which can then be used to form polymeric coatings. The stabilized metal salt powder may also be added to a wide variety of coating formulations. The amount of stabilized metal salt powder to be added may be readily calculated to provide the desired level of functionality. For example, where the metal salt is antimicrobial, the amount of metal salt powder added to the bulk polymer or coating formulation may be readily calculated to provide the desired level of antimicrobial metal ion.
- In order to illustrate the invention the following examples are included. These examples do not limit the invention. They are meant only to suggest a method of practicing the invention. Those knowledgeable in contact lenses as well as other specialties may find other methods of practicing the invention. However, those methods are deemed to be within the scope of this invention.
- Particle size was measured using laser light scattering or dynamic light scattering. For samples with a particle size range greater than about 500nm a Horiba-LA930 laser diffraction particle size analyzer was used. The instrument check was performed from the blank % T values. One mL of the sample solution was introduced into the circulation bath which contained 150 mL of water as medium. A relative refractive index of 1.7-0.1 i and a circulation speed of 5 was used. The samples were ultrasonicated for two minutes prior to measurement using ultrasonication in the instrument. Triton° X-100 (commercially available from Union Carbide) (0.1%) was used as a surfactant in the analysis. Triplicate analysis was performed and the traces were compared to make sure that they coincided with each other. The instrument provided a report containing a graph of the particle size distribution along with values for the mean particle size.
- For samples with a particle size range less than about 500 nm a Malvern 4700 dynamic light scattering apparatus was used. The instrument check was performed prior to analysis of the samples using NIST traceable standard size polystyrene particles. One ml of the sample was diluted to 20 ml with water and the samples were sonicated for one minute using Branson Ultrasonic probe and both relative refractive index and viscosity values were entered in the software. The instrument provides a report containing a graph of the particle size distribution along with values for the mean particle size.
- Metal agent and salt precursor solutions were formed as follows: 10,000 ppm AgNO3 was dissolved with stirring in 200 gm of a 50 w/w% solution of PVP K12 in Dl water. Nal (10,000 ppm) was dissolved with stirring in 200 gm of a 50 w/w% solution of PVP K12 in Dl water. The metal salt solution containing AgNO3 was added to the salt precursor solution at a rate of 200 gm/hour with stirring at 2013 rpm. The metal salt solution was spray dried in air. The inlet temperature was 185° C., the outlet temperature was 90° C. and the feed rate was 2.7 kg/hr. The stabilized Agl nanoparticles had a water content of less than 5 weight %.
- A 100,000 ppm solution of PVP K12 was made in Dl water. This solution (solution A) provided the base for making Nal and AgNO3 solutions. Solutions of approximately 1500 ppm, 5000 ppm and 10000 ppm of each of Nal and AgNO3 were made. Each solution was stirred until no visible particles were observed. A 20 mL portion of Nal solution was placed in a clean jar and magnetic stirrer was placed inside. The stirrer was set at 300 rpm and 20 ml. of AgNO3 was added to the Nal solution at the rate shown in Table 1, below. All mixing was conducted at ambient temperature. The haze of the solution was subjectively assessed at the end of the listed addition time and results are reported in Table 1, below. The Example was repeated for each concentration and addition rate shown in Table 1.
-
TABLE 1 Addn rate Addn Time Ex 2 Ex 3 Ex 4 (ml/sec) (sec) 1500 ppm 5000 ppm 10,000 ppm 20 1 clear milky Milky 4 5 clear Mild haze Milky 2 10 clear clear Mild haze 1 20 clear clear Clear 0.67 30 clear clear Clear - Examples 2-4 were repeated, except that the Nal solution was added to the AgNO3 solution. The results are shown in Table 2, below.
-
TABLE 2 Addn rate Addn Time Ex 5 Ex 6 Ex 7 (ml/sec) (sec) 1500 ppm 5000 ppm 10,000 ppm 20 1 clear milky Milky 4 5 clear milky Milky 2 10 clear milky Milky 1 20 Clear Milky Mild haze 0.67 30 Clear Clear Clear - Example 7 was repeated, except that the metal agent and salt precursor solutions were mixed for about ˜5 days, and then batch-wise mixed (poured together in about 1 second). The result was a clear silver iodide solution.
- Approximately 10 mL of 700 ppm AgNO3 solution was formed in PVP K12:Dl water solution at the PVP concentrations shown in Table 3 (1% to 35% PVP K12 in Dl water). Each AgNO3 solution was dropwise-added to 10 mL of 1100 ppm Nal/Dl solution (no PVP) with manual shaking to form dispersions. Example 9 was milky. The remaining Examples remained clear throughout addition of the AgNO3. Particle size measurements were carried out on the resulting Agl dispersions using laser light scattering (Examples 9) and photon correlation spectrophotometry (Examples 10-15). Data is reported as z-average of the particle size distribution
-
TABLE 3 Particle Size Ex # [PVP K12] (wt %) (nm) 9 0% 10600 10 1% 270 11 2% 40 12 10% 540 13 15% 400 14 25% 40 15 35% 20 - The data in Table 3 clearly shows that the presence of PVP during metal salt formation decreases particle size substantially (at least two orders of magnitude).
- Example 10 was repeated, except the dispersing agents listed in Table 4 were used instead of PVP, and at the concentrations listed in Table 4. Particle size measurements were carried out on the resulting Agl dispersions using laser light scattering (16, 17 and 19) and photon correlation spectrophotometry (18, 20). Data is reported as z-average of the particle size distribution.
-
TABLE 4 Particle Size Ex # Dispersing agent (nm) 16 5% PAA 2K 2760 17 5% PEO 10K 7020 18 10% PEO 10K 475 19 GLYCERIN 6380 20 PVA 120K 470
Claims (23)
1. A process comprising
a. forming a first solution comprising at least one sodium iodide salt precursor;
b. forming a second solution comprising a complex formed from at least one silver acetate metal agent and a polyvinyl pyrrolidone dispersing agent in a particle size stabilizing effective amount;
c. adding said second solution to said first solution at a rate sufficient to maintain a clear solution throughout addition and to form a product solution comprising stabilized metal salt particles having a mean particle size of less than about 200 nm;
d. drying said product solution to form an antimicrobial metal salt powder comprising 0.01 to about 10 weight % metal in the antimicrobial metal salt powder.
2. The process of claim 1 wherein said second solution has a metal agent concentration of at least about 1500 ppm.
3. The process of claim 1 wherein the dispersing agent is present in said second solution in a concentration between about 20 and about 50 w/w%.
4. The process of claim 1 wherein said first solution has a salt precursor concentration of at least about 1500 ppm.
5. The process of claim 1 wherein said first solution has a salt precursor concentration of at least about 5000 ppm.
6. The process of claim 1 wherein said first solution has a salt precursor concentration of about 5000 ppm to about 50,000 ppm.
7. The process of claim 1 wherein said mean particle size is less than about 100 nm.
8. The process of claim 1 wherein said mean particle size is less than about 50 nm.
9. The process of claim 1 wherein said first and second solutions are aqueous solutions.
10. The process of claim 1 wherein said product solution has a viscosity of less than about 50 cps.
11. The process of claim 1 wherein said first solution is stirred as said second solution is added.
12. The process of claim 9 wherein said solutions are maintained at a pressure between about ambient and about 40 mbar during said adding step.
13. (canceled)
14. The process of claim 1 wherein at least one of said first and second solution comprises at least one solvent and said powder comprises less than about 10 wt % of said solvent.
15. The process of claim 14 wherein said powder comprises less than about 5% of said solvent.
16. The process of claim 14 wherein said solvent comprises water.
17-18. (canceled)
19. The process of claim 1 wherein said polyvinyl pyrrolidone and metal agent are present in said second solution in a molar ratio of at least about 1.5.
20. The process of claim 1 wherein said metal salt powder comprises at least one metal salt having a Ksp of less than about 2×10−10 in pure water at 25° C.
21. (canceled)
22. The process of claim 1 wherein said second solution has a metal agent concentration of at least about 5000 ppm.
23. The process of claim 1 wherein said second solution has a metal agent concentration of about 5000 ppm to about 50,000 ppm.
24. A process comprising
a. forming a first solution comprising Nal;
b. forming a second solution comprising a complex formed from silver acetate and polyvinyl pyrrolidone in a particle size stabilizing effective amount;
c. adding said second solution to said first solution at a rate sufficient to maintain a clear solution throughout addition and to form a product solution comprising stabilized Agl particles having a mean particle size of less than about 200 nm;
d. drying said product solution to form an antimicrobial Agl powder comprising 0.01 to about 10 weight % Ag in the antimicrobial Agl powder.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/841,897 US20180103645A1 (en) | 2007-10-08 | 2017-12-14 | Methods for forming stabilized metal salt particles |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/868,914 US20090092538A1 (en) | 2007-10-08 | 2007-10-08 | Methods for forming stabilized metal salt particles |
US15/361,587 US9872501B2 (en) | 2007-10-08 | 2016-11-28 | Methods for forming stabilized metal salt particles |
US15/841,897 US20180103645A1 (en) | 2007-10-08 | 2017-12-14 | Methods for forming stabilized metal salt particles |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/361,587 Division US9872501B2 (en) | 2007-10-08 | 2016-11-28 | Methods for forming stabilized metal salt particles |
Publications (1)
Publication Number | Publication Date |
---|---|
US20180103645A1 true US20180103645A1 (en) | 2018-04-19 |
Family
ID=40227937
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/868,914 Abandoned US20090092538A1 (en) | 2007-10-08 | 2007-10-08 | Methods for forming stabilized metal salt particles |
US15/361,587 Active US9872501B2 (en) | 2007-10-08 | 2016-11-28 | Methods for forming stabilized metal salt particles |
US15/841,897 Abandoned US20180103645A1 (en) | 2007-10-08 | 2017-12-14 | Methods for forming stabilized metal salt particles |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/868,914 Abandoned US20090092538A1 (en) | 2007-10-08 | 2007-10-08 | Methods for forming stabilized metal salt particles |
US15/361,587 Active US9872501B2 (en) | 2007-10-08 | 2016-11-28 | Methods for forming stabilized metal salt particles |
Country Status (13)
Country | Link |
---|---|
US (3) | US20090092538A1 (en) |
EP (2) | EP2207575B1 (en) |
JP (1) | JP5479347B2 (en) |
KR (1) | KR101561859B1 (en) |
CN (1) | CN101951968B (en) |
AR (1) | AR068743A1 (en) |
AU (1) | AU2008311288B2 (en) |
BR (1) | BRPI0818351A2 (en) |
CA (1) | CA2701632A1 (en) |
HK (1) | HK1246701A1 (en) |
RU (1) | RU2436594C1 (en) |
TW (1) | TWI480068B (en) |
WO (1) | WO2009048556A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021215952A1 (en) | 2020-04-24 | 2021-10-28 | Общество С Ограниченной Ответственностью "Индженик" | Method for producing particles of bacteriophages of the genus levivirus |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2543399A3 (en) * | 2009-12-18 | 2013-07-10 | Dentsply IH AB | Medical device for short time use with quickly releasable antibacterial agent |
GB2486190A (en) * | 2010-12-06 | 2012-06-13 | P V Nano Cell Ltd | Concentrated dispersion of nanometric silver particles |
EP2713747B1 (en) | 2011-05-24 | 2023-02-22 | Agienic, Inc. | Compositions and methods for antimicrobial metal nanoparticles |
US9155310B2 (en) | 2011-05-24 | 2015-10-13 | Agienic, Inc. | Antimicrobial compositions for use in products for petroleum extraction, personal care, wound care and other applications |
CN103371182A (en) * | 2012-04-13 | 2013-10-30 | 上海维来新材料有限公司 | Double-complexing nanosilver polymer liquid antibacterial agent and preparation method thereof |
CN102728850B (en) * | 2012-06-20 | 2014-04-02 | 湖北富邦科技股份有限公司 | Method for preparing high-stability polymer coated nano silver cluster |
CN103202317A (en) * | 2013-04-16 | 2013-07-17 | 苏州大学 | Silver iodine complexing antibacterial agent and preparation method thereof |
US20160324892A1 (en) * | 2014-02-07 | 2016-11-10 | Nbc Meshtec Inc. | Bactericidal composition for bacterial skin disease |
JP6700015B2 (en) * | 2014-09-26 | 2020-05-27 | 株式会社Nbcメッシュテック | Antifungal composition |
RU2621301C1 (en) * | 2016-03-24 | 2017-06-01 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Волгоградский государственный технический университет" (ВолгГТУ) | Method of obtaining highly-dispersed stabilized particles of sodium iodide in water solutions |
Family Cites Families (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1758651A (en) * | 1924-05-29 | 1930-05-13 | Lab Of Res Chemotherapy | Chemical emulsion |
US1788334A (en) * | 1929-11-20 | 1931-01-06 | Schneider Lillian | Multiple valve for sectional tubes of vehicle tires |
GB422948A (en) | 1933-05-15 | 1935-01-22 | Dozent Dr Fritz Feigl | Method of producing therapeutically and disinfectantly active substances |
US2040806A (en) * | 1933-05-15 | 1936-05-12 | Feigl Fritz | Substances containing silver and methods of producing the same |
US2072809A (en) * | 1934-10-20 | 1937-03-02 | North American Rayon Corp | Cellulosic spinning solution |
GB474614A (en) | 1935-05-03 | 1937-11-02 | Syngala Fabrik Fuer Chemisch S | Method of producing therapeutically and disinfectantly active substances |
GB476376A (en) | 1936-05-02 | 1937-12-02 | Syngala Fabric Fuer Chemisch S | Method of producing therapeutically and disinfectantly active substances |
US2422688A (en) * | 1942-10-16 | 1947-06-24 | Squibb & Sons Inc | Composition comprising colloidal silver salt of sulfa drug |
US2689609A (en) | 1951-05-14 | 1954-09-21 | James A Butler | Striker plate for perforators |
US2689809A (en) * | 1951-10-08 | 1954-09-21 | Permachem Corp | Self-sterilizing article and its preparation |
US2927052A (en) * | 1953-03-20 | 1960-03-01 | Us Movidyn Corp | Process of producing oligodynamic metal biocides |
US2853414A (en) * | 1953-12-02 | 1958-09-23 | American Sugar Refining Co | Water-insoluble complex of quaternary ammonium salt, a heavy-metal oxide, and an organic colloid and method of preparing same |
GB769799A (en) | 1954-08-30 | 1957-03-13 | Permachem Corp | Improvements in or relating to articles treated so as to have microbicidal properties |
GB777670A (en) | 1954-10-21 | 1957-06-26 | Standard Telephones Cables Ltd | Electric equalising networks |
US3092552A (en) * | 1958-05-19 | 1963-06-04 | Albert C Nolte | Oligodynamic silver compositions and uses |
US3639575A (en) * | 1968-06-19 | 1972-02-01 | Basf Wyandotte Corp | Silver ion gel compositions and method of using the same |
GB1276912A (en) * | 1968-09-05 | 1972-06-07 | Agfa Gevaert Ag | Process for the preparation of silver halide emulsions |
CH621479A5 (en) * | 1977-08-05 | 1981-02-13 | Battelle Memorial Institute | |
US4579731A (en) * | 1979-01-11 | 1986-04-01 | Key Pharmaceuticals, Inc. | Polymeric diffusion burn matrix and method of use |
NO146306C (en) | 1980-12-09 | 1982-09-08 | Tor Christiansen | FUEL AND USE THEREOF. |
US4395478A (en) * | 1981-11-12 | 1983-07-26 | Eastman Kodak Company | Direct-positive core-shell emulsions and photographic elements and processes for their use |
JPS60221043A (en) * | 1984-04-18 | 1985-11-05 | Toyo Jozo Co Ltd | Feed sugar block and breeding method using same |
US5413788A (en) * | 1986-07-03 | 1995-05-09 | Johnson Matthey Public Limited Company | Antimicrobial compositions |
US5019096A (en) * | 1988-02-11 | 1991-05-28 | Trustees Of Columbia University In The City Of New York | Infection-resistant compositions, medical devices and surfaces and methods for preparing and using same |
JP2847455B2 (en) | 1992-07-24 | 1999-01-20 | 富士写真フイルム株式会社 | Silver halide photographic material |
JP3221132B2 (en) * | 1993-01-29 | 2001-10-22 | 日産化学工業株式会社 | Conductive particles and method for producing the same |
US6605751B1 (en) * | 1997-11-14 | 2003-08-12 | Acrymed | Silver-containing compositions, devices and methods for making |
GB9821778D0 (en) * | 1998-10-06 | 1998-12-02 | Unilever Plc | Process and apparatus for the production of a deodorant or antiperspirant composition |
US6716895B1 (en) | 1999-12-15 | 2004-04-06 | C.R. Bard, Inc. | Polymer compositions containing colloids of silver salts |
US7179849B2 (en) * | 1999-12-15 | 2007-02-20 | C. R. Bard, Inc. | Antimicrobial compositions containing colloids of oligodynamic metals |
US20020197299A1 (en) | 2000-12-21 | 2002-12-26 | Vanderlaan Douglas G. | Antimicrobial contact lenses containing activated silver and methods for their production |
WO2003011351A2 (en) * | 2001-08-02 | 2003-02-13 | Johnson & Johnson Vision Care, Inc. | Antimicrobial lenses and methods of their use |
AU2002357050A1 (en) | 2001-12-03 | 2003-06-17 | C.R. Bard, Inc. | Microbe-resistant medical device, microbe-resistant polymeric coating and methods for producing same |
AU2003262951A1 (en) | 2002-08-26 | 2004-03-11 | C.R. Bard, Inc. | Antimicrobial compositions containing colloids of oligodynamic metals |
CN100408106C (en) * | 2002-11-22 | 2008-08-06 | 庄臣及庄臣视力保护公司 | Antimicrobial lenses displaying extended efficacy |
US8425926B2 (en) * | 2003-07-16 | 2013-04-23 | Yongxing Qiu | Antimicrobial medical devices |
US20080063693A1 (en) * | 2004-04-29 | 2008-03-13 | Bacterin Inc. | Antimicrobial coating for inhibition of bacterial adhesion and biofilm formation |
EP1778010B1 (en) * | 2004-07-30 | 2014-06-04 | Kimberly-Clark Worldwide, Inc. | Antimicrobial silver compositions |
CA2529236A1 (en) * | 2004-12-07 | 2006-06-07 | Centre Des Technologies Textiles | New antimicrobial material |
JP4238369B2 (en) * | 2005-09-08 | 2009-03-18 | 国立大学法人九州大学 | Ion conductive fine particles, method for producing the same, and electrochemical device using the same |
JP5068763B2 (en) * | 2005-11-16 | 2012-11-07 | ノバルティス アーゲー | Lens care composition |
JP4959186B2 (en) * | 2005-12-14 | 2012-06-20 | 高砂熱学工業株式会社 | Method for producing antibacterial fine particles |
JP4886540B2 (en) | 2006-03-01 | 2012-02-29 | キヤノン株式会社 | Organic EL element panel |
-
2007
- 2007-10-08 US US11/868,914 patent/US20090092538A1/en not_active Abandoned
-
2008
- 2008-10-07 CA CA2701632A patent/CA2701632A1/en not_active Abandoned
- 2008-10-07 JP JP2010528874A patent/JP5479347B2/en not_active Expired - Fee Related
- 2008-10-07 EP EP08836885.7A patent/EP2207575B1/en not_active Not-in-force
- 2008-10-07 AR ARP080104382A patent/AR068743A1/en not_active Application Discontinuation
- 2008-10-07 EP EP17181166.4A patent/EP3248621A1/en not_active Withdrawn
- 2008-10-07 CN CN200880110414.2A patent/CN101951968B/en not_active Expired - Fee Related
- 2008-10-07 AU AU2008311288A patent/AU2008311288B2/en not_active Ceased
- 2008-10-07 TW TW097138483A patent/TWI480068B/en not_active IP Right Cessation
- 2008-10-07 KR KR1020107010206A patent/KR101561859B1/en active IP Right Grant
- 2008-10-07 RU RU2010118485/15A patent/RU2436594C1/en not_active IP Right Cessation
- 2008-10-07 WO PCT/US2008/011554 patent/WO2009048556A1/en active Application Filing
- 2008-10-07 BR BRPI0818351-1A2A patent/BRPI0818351A2/en not_active Application Discontinuation
-
2010
- 2010-11-29 HK HK18106351.0A patent/HK1246701A1/en unknown
-
2016
- 2016-11-28 US US15/361,587 patent/US9872501B2/en active Active
-
2017
- 2017-12-14 US US15/841,897 patent/US20180103645A1/en not_active Abandoned
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021215952A1 (en) | 2020-04-24 | 2021-10-28 | Общество С Ограниченной Ответственностью "Индженик" | Method for producing particles of bacteriophages of the genus levivirus |
Also Published As
Publication number | Publication date |
---|---|
CN101951968B (en) | 2014-12-03 |
JP2010540680A (en) | 2010-12-24 |
RU2436594C1 (en) | 2011-12-20 |
KR20100112546A (en) | 2010-10-19 |
US20170071211A1 (en) | 2017-03-16 |
JP5479347B2 (en) | 2014-04-23 |
TWI480068B (en) | 2015-04-11 |
AU2008311288A1 (en) | 2009-04-16 |
AR068743A1 (en) | 2009-12-02 |
US20090092538A1 (en) | 2009-04-09 |
HK1246701A1 (en) | 2018-09-14 |
TW200932291A (en) | 2009-08-01 |
EP2207575A1 (en) | 2010-07-21 |
EP3248621A1 (en) | 2017-11-29 |
WO2009048556A1 (en) | 2009-04-16 |
EP2207575B1 (en) | 2017-08-23 |
BRPI0818351A2 (en) | 2014-10-14 |
AU2008311288B2 (en) | 2013-09-12 |
US9872501B2 (en) | 2018-01-23 |
KR101561859B1 (en) | 2015-10-20 |
CA2701632A1 (en) | 2009-04-16 |
CN101951968A (en) | 2011-01-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9872501B2 (en) | Methods for forming stabilized metal salt particles | |
EP2713747B1 (en) | Compositions and methods for antimicrobial metal nanoparticles | |
US20120301528A1 (en) | Compositions and methods for antimicrobial metal nanoparticles | |
US20110129536A1 (en) | Nanocomposite materials based on metallic nanoparticles stabilized with branched polysaccharides | |
JP5599470B2 (en) | Antifungal material | |
Sultan et al. | Physically-crosslinked hydroxyethyl cellulose-g-poly (acrylic acid-co-acrylamide)-Fe3+/silver nanoparticles for water disinfection and enhanced adsorption of basic methylene blue dye | |
El-Sherif et al. | Hydrogels as template nanoreactors for silver nanoparticles formation and their antimicrobial activities | |
Kostic et al. | Multifunctional ternary composite films based on PLA and Ag/alginate microbeads: Physical characterization and silver release kinetics | |
KR20190021556A (en) | Disinfectant comprising silver-citric acid colloid and method of manufacturing the same | |
Montaser et al. | Facile way for synthesis silver nanoparticles for obtaining antibacterial textile fabrics | |
US20130171266A1 (en) | Compositions and methods for antimicrobial metal nanoparticles | |
US20220193255A1 (en) | Chlorhexidine systems and methods for obtaining same | |
WO2023017834A1 (en) | Disinfectant, disinfectant film, and disinfectant beads | |
Mao et al. | Modification of physicochemical, antioxidant, and antibacterial properties of chitosan film with curcumin-loaded TA/Fe nanoparticles | |
Abdelghany et al. | WITHDRAWN: Spectroscopic and antibacterial speculation of silver nanoparticles modified chitosan/polyvinyl alcohol polymer blend | |
Nita | Synthesis of antimicrobial polymer composition and in vitro drugs release study | |
Pandey | Nano-biomaterials in Antimicrobial Therapy | |
Salahuddin et al. | Chitosan nanoparticles as a drug delivery system for 1, 2, 4-triazole derivatives: release and antimicrobial activity. | |
Htwe et al. | Doxorubicin-Loaded Carboxymethyl Cellulose/Chitosan/ZnO Nanocomposite Hydrogel Beads as an Anticancer Drug Carrier Agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |